Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-09-19

Clinical Trial Update: A Study Evaluating the Safety and Efficacy of a Second Course of TPX-100 in Subjects Who Previously Received TPX-100 for Patellar Osteoarthritis Involving Both Knees [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating a second course of TPX-100 for knee osteoarthritis; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TPX-100

Snippet

Sponsor: OrthoTrophix, Inc | Conditions: Knee Osteoarthritis | Phase 2 | Status: COMPLETED